Synthesis and antimicrobial activity of pyrrolyl/pyrazolyl arylaminosulfonylmethyl 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles

Chemical and Pharmaceutical Bulletin

Volumn 59, Issue 12, 2011, Pages 1509-1517

  Padmaja, Adivireddy ^a   Muralikrishna, Akkarapalli ^a   Rajasekhar, Chittoor ^a   Padmavathi, Venkatapuram ^a  

^a SRI VENKATESWARA UNIVERSITY   (India)

Author keywords

1,2,4 Triazole; 1,3,4 Thiadiazole; 1,3 Dipolar cycloaddition; Antimicrobial activity; Pyrrolyl pyrazolyl 1,3,4 oxadiazole

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; 1,3,4 OXADIAZOLE DERIVATIVE; 1,3,4 THIADIAZOLE DERIVATIVE; 2 (4 CHLOROPHENYLAMINOSULFONYLMETHYL) 5 (4' 4 CHLOROPHENYL 1'H PYRROL 3' YLSULFONYL METHYL) 1,3,4 OXADIAZOLE; 2 (4 CHLOROPHENYLAMINOSULFONYLMETHYL) 5 (4' 4 CHLOROPHENYL 1'H PYRROL 3' YLSULFONYL METHYL) 1,3,4 THIADIAZOLE; 2 (4 CHLOROPHENYLAMINOSULFONYLMETHYL) 5 (4' 4 CHLOROPHENYL 4',5' DIHYDRO 1'H PYRAZO 3' YLSULFONYLMETHYL) 1,3,4 OXADIAZOLE; 2 (4 CHLOROPHENYLAMINOSULFONYLMETHYL) 5 [(4 CHLOROSTYRYLSULFONYLMETHYL)] 1,3,4 OXADIAZOLE; 2 (4 CHLOROPHENYLAMINOSULFONYLMETHYL) 5 [(4 CHLOROSTYRYLSULFONYLMETHYL)] 1,3,4 THIADIAZOLE; 2 (4 METHYLPHENYLAMINOSULFONYLMETHYL) 5 (4' 4 METHYLPHENYL 1'H PYRROL 3' YLSULFONYL METHYL) 1,3,4 OXADIAZOLE; 2 (4 METHYLPHENYLAMINOSULFONYLMETHYL) 5 (4' 4 METHYLPHENYL 1'H PYRROL 3' YLSULFONYL METHYL) 1,3,4 THIADIAZOLE; 2 (4 METHYLPHENYLAMINOSULFONYLMETHYL) 5 (4' 4 METHYLPHENYL 4',5' DIHYDRO 1'H PYRAZOL 3' YLSULFONYLMETHYL) 1,3,4 OXADIAZOLE; 2 (4 METHYLPHENYLAMINOSULFONYLMETHYL) 5 [(4 METHYLSTYRYLSULFONYLMETHYL)] 1,3,4 OXADIAZOLE; 2 (4 METHYLPHENYLAMINOSULFONYLMETHYL) 5 [(4 METHYLSTYRYLSULFONYLMETHYL)] 1,3,4 THIADIAZOLE; 2 (PHENYLAMINOSULFONYLMETHYL) 5 (4' PHENYL 1'H PYRROL 3' YLSULFONYL METHYL) 1,3,4 THIADIAZOLE; 2 (PHENYLAMINOSULFONYLMETHYL) 5 (4' PHENYL 1'H PYRROL 3' YLSULFONYLMETHYL) 1,3,4 OXADIAZOLE; 2 (PHENYLAMINOSULFONYLMETHYL) 5 (4' PHENYL 4',5' DIHYDRO 1'H PYRAZOL 3' YLSULFONYL METHYL) 1,3,4 OXADIAZOLE; 2 (PHENYLAMINOSULFONYLMETHYL) 5 [(STYRYLSULFONYLMETHYL)] 1,3,4 OXADIAZOLE; 2 (PHENYLAMINOSULFONYLMETHYL) 5 [(STYRYLSULFONYLMETHYL)] 1,3,4 THIADIAZOLE; 4 AMINO 3 (4 CHLOROPHENYLAMINOSULFONYLMETHYL) 5 (4' 4 CHLOROPHENYL 1'H PYRAZOL 3' YLSULFONYLMETHYL) 1,2,4 TRIAZOLE; 4 AMINO 3 (4 CHLOROPHENYLAMINOSULFONYLMETHYL) 5 (4' 4 CHLOROPHENYL 1'H PYRROL 3' YLSULFONYL METHYL) 1,2,4 TRIAZOLE; 4 AMINO 3 (4 CHLOROPHENYLAMINOSULFONYLMETHYL) 5 [(4 CHLOROSTYRYLSULFONYLMETHYL)] 1,2,4 TRIAZOLE; 4 AMINO 3 (4 METHYLPHENYLAMINOSULFONYLMETHYL) 5 (4' 4 METHYLPHENYL 1'H PYRROL 3' YLSULFONYL METHYL) 1,2,4 TRIAZOLE; 4 AMINO 3 (4 METHYLPHENYLAMINOSULFONYLMETHYL) 5 [(4 METHYLSTYRYLSULFONYLMETHYL)] 1,2,4 TRIAZOLE; 4 AMINO 3 (PHENYLAMINOSULFONYLMETHYL) 5 (4' PHENYL 1'H PYRROL 3' YLSULFONYL METHYL) 1,2,4 TRIAZOLE; 4 AMINO 3 (PHENYLAMINOSULFONYLMETHYL) 5 [(STYRYLSULFONYLMETHYL)] 1,2,4 TRIAZOLE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CHLORAMPHENICOL; KETOCONAZOLE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACILLUS SUBTILIS; BACTERICIDAL ACTIVITY; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CURVULARIA LUNATA; CYCLOADDITION; DRUG SYNTHESIS; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIUM CHRYSOGENUM; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; FUNGI; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOSES; OXAZOLES; THIADIAZOLES; TRIAZOLES;

EID: 82955246145     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.59.1509     Document Type: Article

References (34)

1. Wang C. C. C., Dervan P. B., J. Am. Chem. Soc., 123, 8657-8661 (2001).
2. Sharma S. K., Tandon M., Lown J. W., J. Org. Chem., 66, 1030-1034 (2001).
3. Unverferth K., Engel J., Höfgen N., Rostock A., Günther R., Lankau H. J., Menzer M., Rolfs A., Liebscher J., Müller B., Hofmann H. J., J. Med. Chem., 41, 63-73 (1998).
4. Wustrow D. J., Capiris T., Rubin R., Knobelsdorf J. A., Akunne H., Davis M. D., MacKenzie R., Pugsley T. A., Zoski K. T., Heffner T. G., Wise L. D., Bioorg. Med. Chem. Lett., 8, 2067-2070 (1998).
5. Kees K. L., Fitzgerald J. J., Steiner K. E. Jr., Mattes J. F., Mihan B., Tosi T., Mondoro D., McCaleb M. L., J. Med. Chem., 39, 3920-3928 (1996).
6. Chen H. S., Li Z. M., Han Y. F., J. Agric. Food Chem., 48, 5312-5315 (2000).
7. Tanitame A., Oyamada Y., Ofuji K., Terauchi H., Kawasaki M., Wachi M., Yamagishi J., Bioorg. Med. Chem. Lett., 15, 4299-4303 (2005).
8. Meazz G., Bettarini F., La Porta P., Piccardi P., Pest Manag. Sci., 60, 1178-1188 (2004).
9. Penning T. D., Talley J. J., Bertenshaw S. R., Carter J. S., Collins P. W., Docter S., Graneto M. J., Lee L. F., Malecha J. W., Miyashiro J. M., Rogers R. S., Rogier D. J., Yu S. S., Anderson G. D., Burton E. G., Cogburn J. N., Gregory S. A., Koboldt C. M., Perkins W. E., Seibert K., Veenhuizen A. W., Zhang Y. Y., Isakson P. C., J. Med. Chem., 40, 1347-1365 (1997).
10. Kane J. L. Jr., Hirth B. H., Liang B., Gourlie B. B., Nahill S., Barsomian G., Bioorg. Med. Chem. Lett., 13, 4463-4466 (2003).
11. Aggarwal R., Kumar V., Tyagi P., Singh S. P., Bioorg. Med. Chem., 14, 1785-1791 (2006).
12. Rahman V. P. M., Mukhtar S., Ansari W. H., Lemiere G., Eur. J. Med. Chem., 40, 173-184 (2005).
13. Le-Blanc R., Dickson J., Brown T., Stewart M., Pati N. H., VanDerveer D., Arman H., Harris J., Pennington W., Holt H. L. Jr., Lee M., Bioorg. Med. Chem., 13, 6025-6034 (2005).
14. Boiani M., Cerecetto H., González M., Risso M., Olea-Azar C., Piro O. E., Castellano E. E., de Ceráin A. L., Ezpeleta O., Vega A. M., Eur. J. Med. Chem., 36, 771-782 (2001).
15. Boiani M., Cerecetto H., González M., Il Farmaco, 59, 405-412 (2004).
16. Labanauskas L., Kalcas V., Udrenaite E., Gaidelis P., Brukstus A., Dauksas V., Pharmazie, 56, 617-619 (2001).
17. Palaska E., Sahin G., Kelicen P., Durlu N. T., Altinok G., Il Farmaco, 57, 101-107 (2002).
18. Schenone S., Bruno O., Ranise A., Bondavalli F., Filippelli W., Falcone G., Giordano L., Vitelli M. R., Bioorg. Med. Chem., 9, 2149-2153 (2001).
19. Gokce M., Cakir B., Erol K., Sahin M. F., Arch. Pharm., 334, 279-283 (2001).
20. Baldwin J. J., Engelhardt E. L., Hirschmann R., Ponticello G. S., Atkinson J. G., Wasson B. K., Sweet C. S., Scriabine A., J. Med. Chem., 23, 65-70 (1980).
21. Joshi S. D., Vagdevi H. M., Vaidya V. P., Gadaginamath G. S., Eur. J. Med. Chem., 43, 1989-1996 (2008).
22. Kaplancikli Z. A., Turan-Zitouni G., Ozdemir A., Revial G., Eur. J. Med. Chem., 43, 155-159 (2008).
23. Küçükgüzel I., Tatar E., Küçü kgüzel S. G., Rollas S., De Clercq E., Eur. J. Med. Chem., 43, 381-392 (2008).
24. Zampieri D., Mamolo M. G., Laurini E., Fermeglia M., Posocco P., Pricl S., Banfi E., Scialino G., Vio L., Bioorg. Med. Chem., 17, 4693-4707 (2009).
25. Padmavathi V., Reddy S. N., Mahesh K., Chem. Pharm. Bull., 57, 1376-1380 (2009).
26. Padmavathi V., Venugopal Reddy K., Balaiah A., Ramana Reddy T. V., Bhaskar Reddy D., Heteroatom Chem., 13, 677-682 (2002).
27. Ramana Reddy M. V., Reddy S., Synthesis, 1984, 322-323 (1984).
28. Ramana Reddy M. V., Reddy S., Bhaskar Reddy D., Padmavathi V., Synth. Commun., 19, 1101-1107 (1989).
29. Chung K. T., Thomasson W. R., Wu-Yuan C. D., J. Appl. Bacteriol., 69, 498-503 (1990).
30. Azoro C., World J. Biotechnol., 3, 347-357 (2002).
31. Janovska D., Kubikova K., Kokoska L., J. Food Sci., 21, 107-110 (2003).
32. Bishnu J., Sunil L., Anuja S., Kathmandu University J. Science Engineering and Technol., 5, 143-150 (2009).
33. "National committee for clinical laboratory standards methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3d edition; approved standard," NCCLS publication M7-A3; Villanova, PA (1993).
34. "National committee for clinical laboratory standards, reference method for broth dilution antifungal susceptibility testing of yeasts, proposed standard, NCCLS Document M27-P," Villanova, PA (1992).